Skip to main content

Animations

MJFF Publications

5621 - 5630 of 6458 Results
Title
Year
  • Year
  • 2021
  • 2022
  • 2022
  • 2022
  • 2021
  • 2021
  • 2021
  • 2018
  • 2022
  • 2021
  • Summary Details
    OPEN
    Title: Generation of human midbrain organoids from induced pluripotent stem cells
    Journal Name: MNI Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.12688/mniopenres.12816.2
    Citation Count: 18
  • Summary Details
    OPEN
    Title: At a Glance: An Update on Neuroimaging and Retinal Imaging in Alzheimer's Disease and Related Research
    Journal Name: The Journal of Prevention of Alzheimer's Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.14283/jpad.2022.7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signal
    Journal Name: ESANN 2022 proceedings
    Publisher: Ciaco - i6doc.com
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s disease
    Journal Name: Medizinische Genetik
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1515/medgen-2022-2127
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Supplement (online only): Proceedings of the 14th Göttingen Meeting of the German Neuroscience Society 2021
    Journal Name: Neuroforum
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1515/nf-2021-2003
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s Disease
    Journal Name: Neurology
    Publisher: Touch Medical Media, Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Am I My Cousin's Keeper? A Proposal to Protect Relatives of Genetic Database Subjects
    Journal Name: Indiana Health Law Review
    Publisher: IUPUI University Library
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18060/25052
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Леводопа/карбідопа пролонгованого вивільнення в лікуванні хвороби Паркінсона
    Journal Name: INTERNATIONAL NEUROLOGICAL JOURNAL
    Publisher: Publishing House Zaslavsky
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.22141/2224-0713.3.97.2018.133682
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Opicapone in Uk Clinical Practice: effectiveness, Safety and Cost Analysis in Patients With Parkinson’s Disease
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2217/nmt-2021-0057
    Citation Count: 9
  • Summary Details
    OPEN
    Title: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s disease
    Journal Name: Journal of Drug Delivery and Therapeutics
    Publisher: Society of Pharmaceutical Tecnocrats
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.